Technology News and Research

RSS

UNIST selects six extraordinary scholars to be induced as 'Rising-star Distinguished Professor'

UNIST is pleased to announce the selection of 6 extraordinary scholars to be induced as 'Rising-star Distinguished Professor', the highest honor the university can bestow upon faculty members who are under the age of 45.

12 Oct 2018

FutureNeuro and Ergo partner to enhance eHealth infrastructure for providing better epilepsy care

FutureNeuro, the SFI Research Centre for chronic and rare neurological conditions based at RCSI, has announced its partnership with Irish Cloud solution provider Ergo to enhance crucial eHealth infrastructure in Ireland and provide improved monitoring for people living with epilepsy.

11 Oct 2018

Using pulsed electric fields in cancer therapy

Pulsed electric fields are helping fight cancer, whether by inducing tumor cell death or by stimulating the immune system.

11 Oct 2018

Weather seems to affect physical activity level of older adults, study shows

The summer of 2018 has been one of the hottest and driest in recent times in large parts of Norway and Europe. How does weather affect the exercise habits of the elderly? A study of 1200 older adults’ activity level linked to weather data shows that warmer, dry weather is the most inviting.

11 Oct 2018

How Does Amyloid Formation Impact Neurodegenerative Disease?

An interview with Dr Rosie Staniforth discussing her research into amyloid formation and its impact on neurodegenerative diseases.

From Postnova Analytics 11 Oct 2018

Diagnosing Atrial Fibrillation in 30 Seconds

An interview with Glyn Barnes, Marketing Director for AliveCor, about Kardia Mobile and the Kardia Band, the FDA approved devices which can provide a diagnostic quality ECG reading in 30 seconds.

From AliveCor, Inc. 11 Oct 2018

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.

11 Oct 2018

DNA vaccine shown to provide long-term protection from Ebola

A synthetic DNA vaccine has been shown to provide complete and enduring protection from Ebola virus in preclinical studies.

11 Oct 2018

NVIDIA and King’s College London partner to build AI infrastructure for improving patient care

King's College London was today announced as the first partner to adopt the NVIDIA DGX-2 and NVIDIA Clara platform.

11 Oct 2018

Good bacterium in probiotic digestive supplements helps eliminate Staphylococcus aureus

A new study from National Institutes of Health scientists and their Thai colleagues shows that a "good" bacterium commonly found in probiotic digestive supplements helps eliminate Staphylococcus aureus, a type of bacteria that can cause serious antibiotic-resistant infections.

11 Oct 2018

New molecular switch may help develop sophisticated photomedications

Light-activated switches are too small to be seen by the naked eye, but the molecular systems are hard at work in research related to drug design, adaptive materials and data storage.

11 Oct 2018

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Anthony Fitzpatrick, PhD, a Principal Investigator at Columbia's Zuckerman Institute and Columbia University Irving Medical Center, together with scientists from the Mayo Clinic and Boston Children's Hospital, has been awarded $11.3 million to map the three-dimensional structures of protein tangles that accumulate in the human brain.

11 Oct 2018

Research team awarded $3.6 million to assess safety of genome editing

As genome editing technologies quickly advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. They are also bringing to light a number of challenges that need to be addressed before potential treatments can be widely used in patients.

11 Oct 2018

Nail polish labels that promote fewer ingredients are not necessarily safer

Consumers are growing more knowledgeable about the potential health effects of nail polish, and manufacturers have taken action.

11 Oct 2018

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

Kidney dialysis patients who engage in technology-based positive psychology exercises during their treatments may significantly improve their depressive symptoms and quality of life, a new study found.

11 Oct 2018

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

11 Oct 2018

Medidata Cloud streamlines management of medical images for global heart measurement study

Medidata today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World Alliance of Societies of Echocardiography (WASE) Normal Values Study.

10 Oct 2018

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

Synedgen, a company leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutics for infectious and inflammatory conditions, today announced the market launch of Moisyn Rinse for the treatment of the symptoms of xerostomia, or dry mouth. Moisyn Rinse is being distributed by Prisyna, the oral care division of Synedgen.

10 Oct 2018

A new promising method for treating pancreatic cancer

A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to early research by Queen Mary University of London.

10 Oct 2018

PAREXEL develops several new patient-centric solutions to address drug development

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that it has developed several new solutions that take a patient-centric approach to addressing drug development.

From Parexel 10 Oct 2018

Technology News and Research

UNIST selects six extraordinary scholars to be induced as 'Rising-star Distinguished Professor'

FutureNeuro and Ergo partner to enhance eHealth infrastructure for providing better epilepsy care

Using pulsed electric fields in cancer therapy

Weather seems to affect physical activity level of older adults, study shows

How Does Amyloid Formation Impact Neurodegenerative Disease?

Diagnosing Atrial Fibrillation in 30 Seconds

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

DNA vaccine shown to provide long-term protection from Ebola

NVIDIA and King’s College London partner to build AI infrastructure for improving patient care

Good bacterium in probiotic digestive supplements helps eliminate Staphylococcus aureus

New molecular switch may help develop sophisticated photomedications

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Research team awarded $3.6 million to assess safety of genome editing

Nail polish labels that promote fewer ingredients are not necessarily safer

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

Medidata Cloud streamlines management of medical images for global heart measurement study

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

A new promising method for treating pancreatic cancer

PAREXEL develops several new patient-centric solutions to address drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News